Greenough A, Roberton N R
Br Med J (Clin Res Ed). 1985 Feb 23;290(6468):597-600. doi: 10.1136/bmj.290.6468.597.
In a retrospective analysis the records of all (210) infants ventilated to treat the respiratory distress syndrome over three years were reviewed. A mortality of 19% was found. Intraventricular haemorrhage was associated than a significant increase in mortality in infants of less with 30 weeks' gestation (p less than 0.001) and was the commonest cause of death. Pneumothoraces developed in one third of babies regardless of gestational age but were significantly associated with an increase in mortality only in infants of 27-29 weeks' gestation. Patent ductus arteriosus was present in 31 infants and was commoner in babies of very low birth weight. The presence of a patent ductus arteriosus was not associated with decreased survival but was significantly related to an increased need for prolonged respiratory support (p less than 0.001). Thirty six infants developed chronic lung disease, three of whom died. Comparison with data from earlier studies indicated a steady improvement over the past decade in outcome for infants ventilated for the respiratory distress syndrome.
在一项回顾性分析中,对三年内所有(210例)因治疗呼吸窘迫综合征而接受通气治疗的婴儿记录进行了审查。发现死亡率为19%。脑室出血与胎龄小于30周的婴儿死亡率显著增加相关(p<0.001),且是最常见的死亡原因。无论胎龄如何,三分之一的婴儿发生气胸,但仅在胎龄27 - 29周的婴儿中,气胸与死亡率增加显著相关。31例婴儿存在动脉导管未闭,且在极低出生体重儿中更为常见。动脉导管未闭的存在与生存率降低无关,但与延长呼吸支持需求增加显著相关(p<0.001)。36例婴儿患慢性肺病,其中3例死亡。与早期研究数据相比表明,在过去十年中,因呼吸窘迫综合征接受通气治疗的婴儿的预后有稳步改善。